Stephanie Heldner

Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

Single-Chain Antibody Fragment VEGF Inhibitor RTH258 for Neovascular Age-Related Macular Degeneration

Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study

Hepatocellular carcinoma

Hepatocellular carcinoma

Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence

Hepatocellular carcinoma

In diabetic foot infections antibiotics are to treat infection, not to heal wounds

A global view of hepatocellular carcinoma: trends, risk, prevention and management

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial

Ten years of anti-vascular endothelial growth factor therapy

CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis

Pyroptosis: mechanisms and diseases

Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial

Aptamers as targeted therapeutics: current potential and challenges

Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration

Biopsy for advanced hepatocellular carcinoma: results of a multicentre UK audit

The Noninvestigational Use of Tyrosine Kinase Inhibitors in Thyroid Cancer: Establishing a Standard for Patient Safety and Monitoring

Age-related macular degeneration

Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data from an Observational Study

Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma

The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy

Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial

Molecular therapies and precision medicine for hepatocellular carcinoma

VEGF in Signaling and Disease: Beyond Discovery and Development

Sorafenib for the Treatment of Advanced Hepatocellular Cancer – a UK Audit

Hepatocellular carcinoma

Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

Hepatocellular Carcinoma

Update on management of diabetic foot ulcers

AASLD guidelines for the treatment of hepatocellular carcinoma

Sorafenib in Patients with Hepatocellular Carcinoma—Results of the Observational INSIGHT Study

Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Regional differences in sorafenib‐treated patients with hepatocellular carcinoma: GIDEON observational study

Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration

TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON

First interim analysis of the GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib) non-interventional study

Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study

Moxifloxacin in Complicated Skin and Skin Structure Infections (cSSSIs): A Prospective, International, Non-Interventional, Observational Study

GIDEON (Global Investigation of therapeutic DE cisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis